AMGN vs GILD: Which Stock is Better?

Side-by-side comparison of Amgen Inc and Gilead Sciences Inc in 2026

Comparison Updated:

AMGN

Amgen Inc

$330.41

GILD

Gilead Sciences Inc

$124.91

Key Metrics Comparison

MetricAMGNGILDWinner
Market Cap$177.92B$154.99BAMGN
P/E Ratio25.5719.34GILD
EPS (TTM)$12.92$6.46AMGN
Revenue Growth0.1%0.0%AMGN
Gross Margin70.1%78.7%GILD

Analyze AMGN

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is AMGN or GILD a better investment?

Comparing AMGN and GILD: Amgen Inc has a market cap of $177.92B while Gilead Sciences Inc has $154.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between AMGN and GILD?

AMGN (Amgen Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: AMGN or GILD?

Based on P/E ratios, GILD trades at a lower multiple (19.3x vs 25.6x).

Which is growing faster: AMGN or GILD?

AMGN has higher revenue growth at 0.1% vs 0.0% for GILD.

Which company is more profitable: AMGN or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to 70.1% for AMGN.

Which is the larger company: AMGN or GILD?

Amgen Inc (AMGN) is larger with a market cap of $177.92B compared to $154.99B for GILD.

Should I buy AMGN or GILD in 2026?

Both AMGN and GILD have investment merit. AMGN trades at $330.41 while GILD trades at $124.91. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between AMGN and GILD stock?

Key differences: Market Cap ($177.92B vs $154.99B), P/E Ratio (25.6x vs 19.3x), Revenue Growth (0.1% vs 0.0%), Gross Margin (70.1% vs 78.7%).

Popular Stock Comparisons